机译:根据肿瘤微环境免疫型阶段II和III胃癌的体细胞突变谱
Seoul Natl Univ Hosp Dept Pathol Seoul South Korea;
Seoul Natl Univ Bundang Hosp Dept Pathol Seongnam Si Gyeonggi Do South Korea;
Macrogen Inc Seoul South Korea;
Macrogen Inc Seoul South Korea;
Macrogen Inc Seoul South Korea;
Seoul Natl Univ Bundang Hosp Dept Internal Med Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Bundang Hosp Dept Surg Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Bundang Hosp Dept Surg Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Bundang Hosp Dept Surg Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Bundang Hosp Dept Lab Med Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Bundang Hosp Dept Pathol Seongnam Si Gyeonggi Do South Korea;
Seoul Natl Univ Hosp Dept Pathol Seoul South Korea;
Seoul Natl Univ Bundang Hosp Dept Pathol Seongnam Si Gyeonggi Do South Korea;
cancer microenvironment; gastric cancer; high-throughput nucleotide sequencing; programmed cell death 1 ligand 1; tumor-infiltrating lymphocytes;
机译:根据肿瘤微环境免疫型阶段II和III胃癌的体细胞突变谱
机译:体细胞突变谱预测II期和III结直肠癌中的转移性复发
机译:MA 17.02肿瘤免疫微环境和免疫审实在完全切除的阶段IIIa(N2)非小细胞肺癌中的临床影响
机译:基于与癌症基因组分析中的癌症基因同时发生的体细胞突变来鉴定候选癌症基因
机译:具有肿瘤特异性高通量体细胞突变(CHASM)的肿瘤测序研究中检测到的体细胞错义突变的计算评估。
机译:II期和III期结肠癌的基因组分析显示APC突变与III期结肠癌患者的存活率相关
机译:II期和III结肠癌的基因组分析揭示了与III期结肠癌患者的存活相关的APC突变